Inhibikase Therapeutics Reports First Quarter Financial Resu

Company to host conference call on Thursday, May 16, 2024 at 8:00 a.m. ETBOSTON and ATLANTA, May 15, 2024 -- Inhibikase Therapeutics, Inc. , a clinical-stage pharmaceutical company developing...

Related Keywords

Boston , Massachusetts , United States , Atlanta , Georgia , Alex Lobo , Miltonh Werner , Facebook , Nasdaq , Office Of Cardiology , Division Of Cardiology , Sternir Inc , Linkedin , Company Contact , Steam Review , Exchange Commission , Inhibikase Or Company , Division Of Hematologic Malignancies , Youtube , Inhibikase Therapeutics Inc , Abelson Tyrosine Kinases , Chief Executive Officer , Upcoming Milestones , Meeting Minutes , Hematologic Malignancies , Review Team , Pulmonary Arterial Hypertension , Final Meeting Minutes , Abelson Tyrosine Kinase , Abelson Tyrosine , Multiple System Atrophy , Private Securities Litigation Reform Act , Consolidated Statements , Comprehensive Loss , Months Ended March ,